
GC13885
Elesclomol
Also listed as Elesclomol (STA-4783)
Elesclomol (also known as STA-4783), originally identified in a cell-based phenotypic screen for proapoptotic activity, is a novel small-molecule that potently induces apoptosis of cancer cells through the rapid generation of reactive oxygen species (ROS) and the induction of unmanageable levels of oxidative stress
ChemicalCAS488832-69-5MW400.5FormulaC19H20N4O2S2
- CAS number
- 488832-69-5
- Molecular weight
- 400.5
- Formula
- C19H20N4O2S2
- Solubility
- ≥ 20·15mg/mL in DMSO, ≥ 5·68 mg/mL in EtOH with ultrasonic and warming
- InChIKey
- BKJIXTWSNXCKJH-UHFFFAOYSA-N
- Catalogue number
- GC13885
- Brand
- GLPBIO
Computed properties PubChem CID 300471 · XLogP 2.9 · TPSA 129 Ų · H-bond donors 2
- XLogP
- 2.9
- TPSA
- 129 Ų
- H-bond donors
- 2
- H-bond acceptors
- 4
- Rotatable bonds
- 4
- Heavy atoms
- 27
SMILES CN(C(=S)C1=CC=CC=C1)NC(=O)CC(=O)NN(C)C(=S)C2=CC=CC=C2
Computed descriptors from PubChem (CID 300471), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il